This summary presents key updates in the health sector. Highlights include UnitedHealth's tech unit customers adopting ...

MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA; Represents the second EMA approval of an MVA-BN-based vaccine ...

LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in ...

Saad B. Omer Mpox (formerly known as monkeypox) is back in the news. As of early September, the World Health Organization has ...

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from ...

Bavarian Nordic's mpox vaccine has gained approval for use in adolescents by the EU's drug regulator. This move is seen as ...

The European Commission has approved Bavarian Nordic's (OTCPK:BVNRY)(OTCPK:BVNKF) mpox shot for adolescents between 12 and 17 ...

Bavarian Nordic A/S, one of the only companies with a vaccine approved for mpox, has received regulatory approval in Europe ...

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...

The Vaccine Alliance, Gavi, has announced an agreement with Bavarian Nordic to secure 500,000 doses of the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) mpox vaccine for Africa in 2024. This comes ...

One dose of modified vaccinia Ankara-Bavarian Nordic vaccine is moderately effective against mpox infection in at-risk communities.